IL6 and breast cancer: The administration of a drug combination using 5-fluorouracil, doxorubicin, and cyclophosphamide triggers an IL-6-dependent NF-κB signaling cascade, which promotes stemness to non-stem cancer cells and consequently induces MDR in BC [97].